Technology ID
TAB-4849

Thyclotide Peptide Conjugates With Cell Permeability And Inhibitory Activity

E-Numbers
E-033-2023-0
Lead Inventor
Appella, Daniel (NIDDK)
Co-Inventors
Zheng, Hongchao (NIDDK)
Clausse, Victor (NIDDK)
Amarasekara, Harsha (NIDDK)
Development Stages
Discovery
Development Status
Preclinical/ in vitro
ICs
NIDDK

Thyclotides are oligomeric molecules with chiral tetrahydrofuran (THF) diamine units consisting of either R,R or
S,S stereochemistry. Thyclotide sequences with R,R stereochemistry bind to complementary DNA and RNA
sequences with strong affinity and sequence specificity, while thyclotides with S,S stereochemistry have a helical
handedness that does not allow binding to DNA or RNA. Thyclotides are cell permeable and can be used to
suppress microRNA activity in cells. Peptides are oligomeric molecules consisting of amino acids found in
proteins as well as other non-natural amino acids. Peptides are often developed as inhibitors of enzymes and
protein-protein interactions, yet peptides typically are poor drugs as they do not penetrate cell membranes
therefore have low bioactivity. NIDDK investigators have discovered that thyclotides can be covalently
conjugated to peptides that are enzyme inhibitors to enhance the cell permeability of the peptide. Using
thyclotide to enhance peptide cell penetration is a novel way to help peptides gain entry into cells to improve
their bioavailability. Using thyclotides+peptide conjugates may greatly expand the range of therapeutic
applications of peptide inhibitors.

Licensing Contact:
Tong, Betty
tongb@niddk.nih.gov
Phone: 301-451-7836